Kamada Ltd. Presents Data on Inhaled Alpha-1 Antitrypsin in Cystic Fibrosis Patients at the European Respiratory Society Meeting 2009, Vienna
9/14/2009 9:23:09 AM
More...
|
Kamada Ltd. Announces US Distribution Agreement for Intravenous Alpha-1 Antitrypsin
8/27/2009 8:46:39 AM
More...
|
Kamada Ltd.'s Biologics License Application for IV-AAT to Treat Alpha-1 Antitrypsin Deficiency is Accepted for Review by the US FDA
8/4/2009 8:59:46 AM
More...
|
Kamada Ltd. Reports Positive Proof-of-Concept Data for Inhaled Alpha-1 Antitrypsin in Bronchiectasis
6/9/2009 7:25:07 AM
More...
|
Kamada Ltd. Submits U.S. Biologics License Application for the First Liquid, Ready to Use AAT for the Treatment of Alpha-1 Antitrypsin Deficiency
6/2/2009 10:21:22 AM
More...
|
Kamada Ltd. Announces Equity Participation by Hercules; Concludes Financing Series
5/21/2009 9:28:36 AM
More...
|
Kamada Ltd. Raises an Additional Approximately US$10 Million in a Private Allocation of Common Stock
5/20/2009 10:14:59 AM
More...
|
Kamada Ltd. Presents New Data on its Alpha-1 Antitrypsin at the American Thoracic Society Annual Meeting
5/19/2009 8:56:48 AM
More...
|
Kamada Ltd. Raises an Additional US$ 1.5 Million (Approximately) in a Private Allocation of Common Stock
5/11/2009 12:09:19 PM
More...
|
Kamada Ltd. Announces Two Abstracts on Alpha-1 Antitrypsin Accepted for Presentation at the International Conference of the American Thoracic Society
5/5/2009 9:36:11 AM
More...
|
|